+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Anatomic Pathology Testing Market by Test Type, Application, End User, Sample Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904684
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The anatomic pathology testing market is experiencing dynamic transformation, driven by rapid innovation and new clinical demands. Senior decision-makers face an evolving landscape where technology integration, regulatory complexity, and shifting healthcare trends require agile strategy and informed investment.

Market Snapshot: Anatomic Pathology Testing Market

The anatomic pathology testing market grew from USD 45.03 billion in 2024 to USD 47.92 billion in 2025. It is projected to maintain a compound annual growth rate (CAGR) of 6.24%, reaching USD 64.78 billion by 2030. Robust market activity is underpinned by advances in digital platforms, molecular diagnostics, and artificial intelligence, with laboratories and hospitals worldwide prioritizing precision and efficiency in diagnostic workflows.

Anatomic Pathology Testing Market: Scope & Segmentation

This report comprehensively covers the entire value chain, offering insights for strategic planning across segments, applications, end users, and sample types. Strategic leaders will benefit from an in-depth understanding of core technologies and regional diversification.

  • Test Types: Digital pathology, including image analysis software and slide scanners; hematoxylin and eosin staining; immunohistochemistry with monoclonal and polyclonal antibody applications; molecular pathology (fluorescence in situ hybridization, next generation sequencing, polymerase chain reaction); special stains (periodic acid-Schiff, silver, and trichrome)
  • Applications: Testing for genetic disorders (chromosomal and single gene), infectious diseases (bacterial and viral), and oncology, including key tumor types such as breast, lung, and prostate cancer
  • End Users: Diagnostic laboratory networks, standalone diagnostic facilities, hospitals (academic, large, community), and research institutions (academic centers and pharmaceutical companies)
  • Sample Types: Cytology samples, frozen sections for intraoperative evaluation, and tissue biopsies
  • Geographical Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), EMEA (United Kingdom, Germany, France, Russia, Italy, and more), Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia)
  • Leading Companies: Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Sonic Healthcare Limited, Eurofins Scientific SE, SYNLAB Holding GmbH, Unilabs AG, Bio-Reference Laboratories, Inc., ARUP Laboratories, Inc., Dr. Lal PathLabs Limited, Metropolis Healthcare Limited

Key Takeaways for Senior Decision-Makers

  • Integration of digital pathology and molecular platforms is accelerating workflow automation, increasing operational agility, and reducing manual error rates.
  • Emerging partnerships between large laboratory networks and technology providers are vital for scaling advanced diagnostic solutions and broadening access in regional markets.
  • Personalized medicine is gaining prominence, with deeper biomarker discovery and tailored cancer testing protocols guiding clinical interventions and resource allocation.
  • Regulatory changes and rising quality standards require ongoing investment in compliance, standardized operating procedures, and workforce training programs.
  • Artificial intelligence and machine learning are starting to optimize image interpretation, enhancing speed and accuracy while managing increased diagnostic volumes.
  • Growing demand for chronic disease management and infectious disease detection is expected to further diversify testing protocols and drive investment in innovative sample processing techniques.

Tariff Impact: Navigating US Market Complexities

New US tariff measures introduced in 2025 have increased the cost of key reagents, instruments, and disposable supplies. Laboratories are responding by renegotiating contracts, expanding supplier networks, and building inventory buffers to maintain workflow continuity. Domestic manufacturers are also pursuing additional capacity to address potential supply chain disruptions and decrease reliance on imports. These actions demand coordination between procurement, clinical leadership, and finance to balance quality, cost, and operational resilience.

Methodology & Data Sources

This research leverages a rigorous blend of primary interviews and secondary data, including direct input from laboratory directors, procurement managers, and compliance experts. The analysis incorporates peer-reviewed literature, regulatory filings, and industry reports, with robust data triangulation and scenario-based validation ensuring reliability.

Why This Report Matters

  • Empowers executive teams to anticipate changes in technology, regulation, and clinical practice, aiding timely investment decisions.
  • Supports market entry strategy with granular insights into core segments, regional priorities, and evolving partnership models.
  • Enables proactive risk management in procurement and supply planning, particularly under new tariff regimes and variable reimbursement scenarios.

Conclusion

The anatomic pathology testing market demands strategic focus and continued adaptation as laboratories adopt new technologies and respond to regulatory shifts. Executive decision-makers equipped with robust, actionable intelligence will be poised to drive operational excellence and innovation within this highly technical sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Anatomic Pathology Testing Market, by Test Type
8.1. Introduction
8.2. Digital Pathology
8.2.1. Image Analysis Software
8.2.2. Slide Scanners
8.3. Hematoxylin and Eosin Staining
8.4. Immunohistochemistry
8.4.1. Monoclonal Antibody
8.4.2. Polyclonal Antibody
8.5. Molecular Pathology
8.5.1. Fluorescence in Situ Hybridization
8.5.2. Next Generation Sequencing
8.5.3. Polymerase Chain Reaction
8.6. Special Staining
8.6.1. Periodic Acid-Schiff Stain
8.6.2. Silver Stain
8.6.3. Trichrome Stain
9. Anatomic Pathology Testing Market, by Application
9.1. Introduction
9.2. Genetic Disorders
9.2.1. Chromosomal Disorders
9.2.2. Single Gene Disorders
9.3. Infectious Diseases
9.3.1. Bacterial Infections
9.3.2. Viral Infections
9.4. Oncology
9.4.1. Breast Cancer
9.4.2. Lung Cancer
9.4.3. Prostate Cancer
10. Anatomic Pathology Testing Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.2.1. Laboratory Chains
10.2.2. Standalone Laboratories
10.3. Hospitals
10.3.1. Academic Medical Centers
10.3.2. Large Hospitals
10.3.3. Small and Community Hospitals
10.4. Research Institutes
10.4.1. Academic Research Centers
10.4.2. Pharmaceutical Companies
11. Anatomic Pathology Testing Market, by Sample Type
11.1. Introduction
11.2. Cytology Samples
11.3. Frozen Sections
11.4. Tissue Biopsy
12. Americas Anatomic Pathology Testing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Anatomic Pathology Testing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Anatomic Pathology Testing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Laboratory Corporation of America Holdings
15.3.2. Quest Diagnostics Incorporated
15.3.3. Sonic Healthcare Limited
15.3.4. Eurofins Scientific SE
15.3.5. SYNLAB Holding GmbH
15.3.6. Unilabs AG
15.3.7. Bio-Reference Laboratories, Inc.
15.3.8. ARUP Laboratories, Inc.
15.3.9. Dr. Lal PathLabs Limited
15.3.10. Metropolis Healthcare Limited
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ANATOMIC PATHOLOGY TESTING MARKET MULTI-CURRENCY
FIGURE 2. ANATOMIC PATHOLOGY TESTING MARKET MULTI-LANGUAGE
FIGURE 3. ANATOMIC PATHOLOGY TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ANATOMIC PATHOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ANATOMIC PATHOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ANATOMIC PATHOLOGY TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SLIDE SCANNERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HEMATOXYLIN AND EOSIN STAINING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY POLYCLONAL ANTIBODY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY PERIODIC ACID-SCHIFF STAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SILVER STAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TRICHROME STAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY CHROMOSOMAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SINGLE GENE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY LABORATORY CHAINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY STANDALONE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY LARGE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SMALL AND COMMUNITY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ACADEMIC RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY CYTOLOGY SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY FROZEN SECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 88. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 89. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 90. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 91. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 92. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2030 (USD MILLION)
TABLE 93. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 95. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 96. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 97. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 99. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 100. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 101. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 102. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 103. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 104. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 105. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 106. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2030 (USD MILLION)
TABLE 107. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 109. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 110. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 111. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 113. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 114. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 115. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 166. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 173. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 174. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 175. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 176. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 177. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2030 (USD MILLION)
TABLE 178. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 180. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 181. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 182. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 184. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 185. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 186. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 187. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 188. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 189. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 190. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 191. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2030 (USD MILLION)
TABLE 192. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 194. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 195. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 196. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 198. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 199. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 200. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 203. RUSSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 204. RUSSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 205. RUSSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2030 (USD MILLION)
TABLE 206. RUSSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. RUSSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 208. RUSSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 209. RUSSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 210. RUSSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. RUSSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 212. RUSSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 213. RUSSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 215. ITALY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 216. ITALY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 217. ITALY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 218. ITALY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 219. ITALY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2030 (USD MILLION)
TABLE 220. ITALY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. ITALY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 222. ITALY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 223. ITALY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 224. ITALY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. ITALY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 226. ITALY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 227. ITALY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 228. ITALY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 229. SPAIN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 230. SPAIN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 231. SPAIN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 232. SPAIN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 233. SPAIN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2030 (USD MILLION)
TABLE 234. SPAIN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. SPAIN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 236. SPAIN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 237. SPAIN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 238. SPAIN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. SPAIN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 240. SPAIN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 241. SPAIN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 242. SPAIN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2030 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 258. SAUDI ARABIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 260. SAUDI ARABIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2030 (USD MILLION)
TABLE 262. SAUDI ARABIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 264. SAUDI ARABIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 266. SAUDI ARABIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 271. SOUTH AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 272. SOUTH AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 274. SOUTH AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2030 (USD MILLION)
TABLE 276. SOUTH AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 285. DENMARK ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 286. DENMARK ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 287. DENMARK ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 288. DENMARK ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 289. DENMARK ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2030 (USD MILLION)
TABLE 290. DENMARK ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. DENMARK ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 292. DENMARK ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 293. DENMARK ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 294. DENMARK ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. DENMARK ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 296. DENMARK ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 297. DENMARK ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 298. DENMARK ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 299. NETHERLANDS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 300. NETHERLANDS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 301. NETHERLANDS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 302. NETHERLANDS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 303. NETHERLANDS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SPECIAL STAINING, 2018-2030 (USD MILLION)
TABLE 304. NETHERLANDS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. NETHERLANDS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 306. NETHERLANDS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 307. NETHERLANDS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 308. NETHERLANDS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. NETHERLANDS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY D

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Anatomic Pathology Testing market report include:
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Sonic Healthcare Limited
  • Eurofins Scientific SE
  • SYNLAB Holding GmbH
  • Unilabs AG
  • Bio-Reference Laboratories, Inc.
  • ARUP Laboratories, Inc.
  • Dr. Lal PathLabs Limited
  • Metropolis Healthcare Limited

Table Information